関連する実験動画
Updated: May 4, 2026

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
1.6K
子宮頸がんにおけるゲノム変異の風景
Akinyemi I Ojesina1, Lee Lichtenstein2, Samuel S Freeman3
11] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA [3].
Nature
|January 7, 2014
まとめ
子宮頸がんに関する新しいゲノム洞察は,MAPK1,HLA-B,EP300,FBXW7.7で以前未知の体内変異を明らかにしています. ヒューマン・パピローマウイルス (HPV) 関連がんにおけるこれらの発見は,潜在的な新しい治療戦略を提供している.
科学分野:
- 腫瘍学 腫瘍学
- ゲノミクスゲノミクスとは
- ウイルス学 ウイルス学 ウイルス学
背景:
- 子宮頸がんは,世界中で女性の死亡率を大幅に引き起こす原因です.
- 高リスクヒトパピロマウイルス (HPV) は,既定の病原体である.
- 以前の研究で,子宮頸がんの病原性における体内変異とコピー数の変化が特定されました.
研究 の 目的:
- 子宮頸がんにおける新たな体性ゲノム変異を特定する.
- スクアモス細胞癌とアデノカルシノーマのゲノムプロフィールを比較する.
- HPV統合と遺伝子発現の関係を調査する.
主な方法:
- 115個の子宮頸がんと正常なペアの全エクソームシーケンシング.
- 79例のトランスクリプトーム配列解析.
- 14の腫瘍と正常なペアの全ゲノム配列解析.
主要な成果:
- MAPK1,HLA-B,EP300,FBXW7,NFE2L2,TP53,ERBB2の再発性突然変異が表皮細胞癌で確認されました.
- アデノカルシノーマにおける体内のELF3およびCBFB変異を発見した.
- スクアモス細胞癌において,明確な置換パターン (Tp*C部位) が観察されました.
- HPV統合部位で遺伝子の発現が上昇していることが判明しました.
結論:
- 子宮頸がんにおける再発性ゲノム変異は,治療戦略の新たなターゲットを提供します.
- 子宮頸部状細胞癌とアデノカルシノーマの間には,異なる分子亜型が存在する.
- HPV統合は局所的な遺伝子発現に影響を与え,腫瘍の発達に潜在的に影響を及ぼします.
関連する概念動画
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cellular Adaptation IV: Dysplasia and Metaplasia
49
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
49
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K

